Vedolizumab (anti-alpha4beta7-integrin) is a humanized IgG1 monoclonal antibody that targets the alpha4beta7 integrin for the treatment of ulcerative colitis and Crohns disease[1][2].
Molecular Weight:
(146.868 kDa)
Purity:
99.90
CAS Number:
[943609-66-3]
Target:
Integrin
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted